Century Therapeutics Inc (IPSC)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | HEALTH CARE |
| CEO: | Osvaldo Flores |
| Employees: | 170 |
| Web site: | centurytx.com |
|
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA, PA, 19104
215-981-4000
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Century Therapeutics, Inc. develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, which targets CD19 for relapsed, refractory B-cell lymphoma. It is also developing a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma.